Forian (NASDAQ:FORA) Stock Price Up 1% – Still a Buy?

Forian Inc. (NASDAQ:FORA)’s stock price rose 1% during mid-day trading on Tuesday . The stock traded as high as $2.06 and last traded at $2.05. Approximately 4,898 shares were traded during trading, a decline of 56% from the average daily volume of 11,125 shares. The stock had previously closed at $2.03.

Analyst Ratings Changes

Separately, Roth Mkm reissued a “buy” rating and set a $5.00 price objective on shares of Forian in a report on Thursday, November 14th.

Forian Price Performance

The stock has a fifty day simple moving average of $2.05 and a two-hundred day simple moving average of $2.26. The firm has a market capitalization of $63.58 million, a P/E ratio of -22.78 and a beta of 1.05.

Institutional Investors Weigh In On Forian

An institutional investor recently bought a new position in Forian stock. Caprock Group LLC bought a new stake in Forian Inc. (NASDAQ:FORA) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 86,784 shares of the company’s stock, valued at approximately $230,000. Caprock Group LLC owned approximately 0.28% of Forian at the end of the most recent reporting period. 19.25% of the stock is owned by institutional investors and hedge funds.

About Forian

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.